Immunotherapeutic approaches to curtail COVID-19
COVID-19, the disease induced by the recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has imposed an unpredictable burden on the world. Drug repurposing has been employed to rapidly find a cure; but despite great efforts, no drug or vaccine is presently available for tr...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12346
- Acceso en línea:
- https://doi.org/10.1016/j.intimp.2020.106924
http://hdl.handle.net/20.500.12010/12346
- Palabra clave:
- COVID-19
Pandemic
Severe acute respiratory syndrome coronavirus 2
Antibodies
Plasma therapy
Immunotherapy
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido